These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 18585408)
21. Effects of covalent dimerization on the structure and function of the carboxy-terminal fragment of neuropeptide Y. Uegaki K; Murase S; Nemoto N; Kobayashi Y; Yoshikawa S; Yumoto N Biochem Biophys Res Commun; 1997 Dec; 241(3):737-43. PubMed ID: 9434778 [TBL] [Abstract][Full Text] [Related]
22. Role of G-protein beta gamma subunits in the augmentation of P2Y2 (P2U)receptor-stimulated responses by neuropeptide Y Y1 Gi/o-coupled receptors. Selbie LA; King NV; Dickenson JM; Hill SJ Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):153-8. PubMed ID: 9359846 [TBL] [Abstract][Full Text] [Related]
23. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors. Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209 [TBL] [Abstract][Full Text] [Related]
24. Importance of a N-terminal aspartate in the internalization of the neuropeptide Y Y2 receptor. Parker SL; Parker MS; Wong YY; Sah R; Balasubramaniam A; Sallee F Eur J Pharmacol; 2008 Oct; 594(1-3):26-31. PubMed ID: 18700141 [TBL] [Abstract][Full Text] [Related]
25. Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors. Körner M; Reubi JC J Neuropathol Exp Neurol; 2008 Aug; 67(8):741-9. PubMed ID: 18648328 [TBL] [Abstract][Full Text] [Related]
26. A generic method for the production of cell lines expressing high levels of 7-transmembrane receptors. Koller KJ; Whitehorn EA; Tate E; Ries T; Aguilar B; Chernov-Rogan T; Davis AM; Dobbs A; Yen M; Barrett RW Anal Biochem; 1997 Jul; 250(1):51-60. PubMed ID: 9234898 [TBL] [Abstract][Full Text] [Related]
27. Characterization of NPY receptor subtypes Y2 and Y7 in rainbow trout Oncorhynchus mykiss. Larsson TA; Larson ET; Fredriksson R; Conlon JM; Larhammar D Peptides; 2006 Jun; 27(6):1320-7. PubMed ID: 16359756 [TBL] [Abstract][Full Text] [Related]
28. Stimulation of neuropeptide Y-mediated calcium responses in human SMS-KAN neuroblastoma cells endogenously expressing Y2 receptors by co-expression of chimeric G proteins. Dautzenberg FM Biochem Pharmacol; 2005 May; 69(10):1493-9. PubMed ID: 15857613 [TBL] [Abstract][Full Text] [Related]
29. Prejunctional neuropeptide Y receptors in human kidney and atrium. Rump LC; Riess M; Schwertfeger E; Michel MC; Bohmann C; Schollmeyer P J Cardiovasc Pharmacol; 1997 May; 29(5):656-61. PubMed ID: 9213209 [TBL] [Abstract][Full Text] [Related]
30. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family. Zou C; Kumaran S; Markovic S; Walser R; Zerbe O Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100 [TBL] [Abstract][Full Text] [Related]
31. Neuropeptide Y (NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: combined anorectic effects of Y2 and Y4 receptor-selective agonists. Balasubramaniam A; Joshi R; Su C; Friend LA; James JH Peptides; 2007 Feb; 28(2):235-40. PubMed ID: 17204349 [TBL] [Abstract][Full Text] [Related]
32. A G alpha i RNA-antisense expression strategy to investigate coupling of peptide YY/neuropeptide Y receptor to G alpha i. Voisin T; Lorinet AM; Goumain M; Laburthe M Methods Mol Biol; 2000; 153():115-28. PubMed ID: 10957989 [No Abstract] [Full Text] [Related]
33. Novel non-peptidic neuropeptide Y Y2 receptor antagonists. Jablonowski JA; Chai W; Li X; Rudolph DA; Murray WV; Youngman MA; Dax SL; Nepomuceno D; Bonaventure P; Lovenberg TW; Carruthers NI Bioorg Med Chem Lett; 2004 Mar; 14(5):1239-42. PubMed ID: 14980673 [TBL] [Abstract][Full Text] [Related]
34. A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes. Schneider E; Mayer M; Ziemek R; Li L; Hutzler C; Bernhardt G; Buschauer A Chembiochem; 2006 Sep; 7(9):1400-9. PubMed ID: 16888730 [TBL] [Abstract][Full Text] [Related]
35. High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia. Körner M; Waser B; Reubi JC Clin Cancer Res; 2004 Dec; 10(24):8426-33. PubMed ID: 15623622 [TBL] [Abstract][Full Text] [Related]
36. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors. Teixeira L; Sousa DM; Nunes AF; Sousa MM; Herzog H; Lamghari M J Cell Biochem; 2009 Aug; 107(5):908-16. PubMed ID: 19459152 [TBL] [Abstract][Full Text] [Related]
37. Differential coupling of the vasopressin V1b receptor through compartmentalization within the plasma membrane. Orcel H; Albizu L; Perkovska S; Durroux T; Mendre C; Ansanay H; Mouillac B; Rabié A Mol Pharmacol; 2009 Mar; 75(3):637-47. PubMed ID: 19047484 [TBL] [Abstract][Full Text] [Related]
38. Modifying the conserved C-terminal tyrosine of the peptide hormone PYY3-36 to improve Y2 receptor selectivity. Pedersen SL; Holst B; Vrang N; Jensen KJ J Pept Sci; 2009 Nov; 15(11):753-9. PubMed ID: 19739125 [TBL] [Abstract][Full Text] [Related]
39. Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity. Balasubramaniam A; Mullins DE; Lin S; Zhai W; Tao Z; Dhawan VC; Guzzi M; Knittel JJ; Slack K; Herzog H; Parker EM J Med Chem; 2006 Apr; 49(8):2661-5. PubMed ID: 16610810 [TBL] [Abstract][Full Text] [Related]
40. Complex plastic changes in the neuropeptide Y system during ethanol intoxication and withdrawal in the rat brain. Olling JD; Ulrichsen J; Christensen DZ; Woldbye DP J Neurosci Res; 2009 Aug; 87(10):2386-97. PubMed ID: 19267419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]